You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Medtronic
Express Scripts
AstraZeneca
Mallinckrodt

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Tideglusib

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Tideglusib?

Tideglusib is an investigational drug.

There have been 6 clinical trials for Tideglusib. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2020.

The most common disease conditions in clinical trials are Myotonic Dystrophy, Alzheimer Disease, and Autistic Disorder. The leading clinical trial sponsors are Noscira SA, AMO Pharma Limited, and McMaster University.

There are six US patents protecting this investigational drug and sixty-seven international patents.

Recent Clinical Trials for Tideglusib
TitleSponsorPhase
Efficacy and Safety of Tideglusib in Congenital Myotonic DystrophyAMO Pharma LimitedPhase 2/Phase 3
Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum DisordersHolland Bloorview Kids Rehabilitation HospitalPhase 2
Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum DisordersMcMaster UniversityPhase 2

See all Tideglusib clinical trials

Clinical Trial Summary for Tideglusib

Top disease conditions for Tideglusib
Top clinical trial sponsors for Tideglusib

See all Tideglusib clinical trials

US Patents for Tideglusib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tideglusib   Start Trial Compositions and methods for treating cancers CEDARS-SINAI MEDICAL CENTER (Los Angeles, CA)   Start Trial
Tideglusib   Start Trial Compositions and methods for treating cancers CEDARS-SINAI MEDICAL CENTER (Los Angeles, CA)   Start Trial
Tideglusib   Start Trial GSK-3 inhibitors Noscira, S.A. (Madrid, ES)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Medtronic
Express Scripts
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.